TRPV4通过调控角质形成细胞ATP及神经免疫系统影响银屑病发展
研究利用人银屑病皮肤样本和咪喹莫特诱导的小鼠银屑病样模型,发现银屑病皮损角质形成细胞TRPV4高表达;Trpv4敲除小鼠皮炎较轻,表皮厚度、CD3+ T细胞和CD68+巨噬细胞浸润及Il17a、Il17f、Il23 mRNA表达均显著降低,神经肽和PGP9.5表达显著降低;体外TRPV4敲低显著抑制人和小鼠角质形成细胞ATP释放;TRPV4拮抗剂显著有效预防银屑病样皮炎进展。结论:TRPV4介导角质形成细胞来源ATP表达并增加神经肽分泌,导致IL-23/Th17反应激活和放大,可作为银屑病新治疗靶点。
要点
- 银屑病皮损角质形成细胞TRPV4高表达。
- Trpv4敲除小鼠银屑病样皮炎较轻,表皮厚度及CD3+ T细胞、CD68+巨噬细胞浸润显著降低。
- TRPV4拮抗剂显著有效预防小鼠银屑病样皮炎进展。
核心结论
- TRPV4介导角质形成细胞来源ATP表达并增加神经肽分泌,导致IL-23/Th17反应激活和放大,可作为银屑病新治疗靶点。
研究设计与样本
- 使用人银屑病皮肤样本和咪喹莫特诱导的银屑病样小鼠模型,并比较Trpv4敲除小鼠与野生型小鼠。
主要发现
- 人银屑病皮肤角质形成细胞TRPV4高表达。
- 咪喹莫特诱导模型中Trpv4敲除小鼠较野生型小鼠皮炎更轻。
- 敲除小鼠表皮厚度显著降低,浸润CD3+ T细胞和CD68+巨噬细胞数量少。
- 敲除小鼠Il17a、Il17f和Il23 mRNA表达降低。
- 敲除小鼠神经肽和神经元标记PGP9.5表达显著降低。
临床怎么用
- TRPV4可作为银屑病的新型治疗靶点。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TRPV4 is a calcium ion channel that is widely expressed in various cells. It is also involved in physiological and pathological processes. However, the role of TRPV4 in psoriasis remains unknown. We aimed to investigate the role of TRPV4 in psoriasis using human psoriasis skin samples and an imiquimod-induced psoriasis-like mouse model. Keratinocytes in human psoriasis skin had high TRPV4 expression. Trpv4-knockout mice had less severe dermatitis than wild-type mice in the imiquimod-induced mouse model. Knockout mice had significantly reduced epidermal thickness and a low number of infiltrated CD3+ T cells and CD68+ macrophages on the basis of histopathological studies and decreased mRNA expression of Il17a, Il17f, and Il23, as detected through qPCR. Furthermore, knockout mice had a significantly low expression of neuropeptides and the neuron marker PGP9.5. Adenosine triphosphate release was significantly suppressed by TRPV4 knockdown in both human and mouse keratinocytes in vitro. Finally, treatment with TRPV4 antagonist was significantly effective in preventing the progression of psoriasis-like dermatitis. In conclusion, TRPV4 mediates the expression of keratinocyte-derived adenosine triphosphate and increases the secretion of neuropeptides, resulting in the activation and amplification of IL-23/Th17 responses. Hence, TRPV4 can serve as a novel therapeutic target in psoriasis.
引用
- Amalia SN, Baral H, Fujiwara C, et al. TRPV4 Regulates the Development of Psoriasis by Controlling Adenosine Triphosphate Expression in Keratinocytes and the Neuroimmune System. J Invest Dermatol. 2023. PMID: 37263487. doi:10.1016/j.jid.2023.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。